Literature DB >> 6785275

Urinary oligosaccharides of GM1-gangliosidosis. Different excretion patterns of oligosaccharides in the urine of type 1 and type 2 subgroups.

K Yamashita, T Ohkura, S Okada, H Yabuuchi, A Kobata.   

Abstract

Oligosaccharide patterns obtained by gel filtration of the urine of GM1-gangliosidosis Type 1 patients are quite different from those of GM1-gangliosidosis Type 2. By studies of oligosaccharides in the four major peaks obtained from the Type 1 subgroup using sequential exoglycosidase digestion, methylation analysis, and periodate oxidation, the structures of 15 oligosaccharides: Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 3Man beta 1 leads to 4GlcNAc, Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 6Man beta 1 leads to 4GlcNAc, Man alpha 1 leads to 6(Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 3)Man beta 1 leads to 4GlcNAc, Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 6(Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 3)Man beta 1 leads to 4GlcNAc, Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 6[Gal beta 1 leads to 4GlcNAc beta 1 leads to 4(Gal beta 1 leads to 4GlcNAc beta 1 leads to 2)Man alpha 1 leads to 3]Man beta 1 leads to 4GlcNAc, Gal beta 1 leads to 4GlcNAc beta 1 leads to 6(Gal beta 1 leads to 4GlcNAc beta 1 leads to 2)Man alpha 1 leads to 6(Gal beta 1 leads to 4Glc NAc beta 1 leads to 2Man alpha 1 leads to 3)Man beta 1 leads to 4GlcNAc, Gal beta 1 leads to 4GlcNAc beta 1 leads to 6(Gal beta 1 leads to 4GlcNAc beta 1 leads to 2)Man alpha 1 leads to 6[Gal beta 1 leads to 4GlcNAc beta 1 leads to 4(Gal beta 1 leads to 4GlcNAc beta 1 leads to 2)Man alpha 1 leads to 3]Man beta 1 leads to 4GlcNAc, Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 6, and 3(Gal beta 1 leads to 4GlcNAc beta 1 leads to 3Gal beta 1 leads to 4GlcNAc beta 1 leads to 2Man alpha 1 leads to 3 and 6)Man beta 1 leads to 4GlcNAc, (formula see text) were elucidated. The amounts of total oligosaccharides excreted in the urine of the Type 2 subgroup were approximately one-tenth of those of Type 1. Moreover, the last eight oligosaccharides shown above, which have a Gal beta 1 leads to 4GlcNAc beta 1 leads to 3Gal beta 1 leads to 4GlcNAc beta 1 leads to outer chain, were completely missing in the urine of Type 2.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785275

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  GM1 gangliosidosis (type 1) in a cat.

Authors:  C G Barker; W F Blakemore; A Dell; A C Palmer; P R Tiller; B G Winchester
Journal:  Biochem J       Date:  1986-04-01       Impact factor: 3.857

2.  Porcine, mouse and human galactose 3-O-sulphotransferase-2 enzymes have different substrate specificities; the porcine enzyme requires basic compounds for its catalytic activity.

Authors:  Akira Seko; Jun-ichi Sumiya; Katsuko Yamashita
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

3.  Activation of beta1,3-N-acetylglucosaminyltransferase-2 (beta3Gn-T2) by beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing poly-N-acetyllactosamine chains in differentiated HL-60 cells.

Authors:  Akira Seko; Katsuko Yamashita
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

4.  Prenatal diagnosis of GM1 gangliosidosis by detection of galactosyl-oligosaccharides in amniotic fluid with high-performance liquid chromatography.

Authors:  T G Warner; A D Robertson; A K Mock; W G Johnson; J S O'Brien
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

5.  Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography-mass spectrometry.

Authors:  Cees Bruggink; Ben J H M Poorthuis; André M Deelder; Manfred Wuhrer
Journal:  Anal Bioanal Chem       Date:  2012-04-20       Impact factor: 4.142

6.  Characterization of glycan substrates accumulating in GM1 Gangliosidosis.

Authors:  Roger Lawrence; Jeremy L Van Vleet; Linley Mangini; Adam Harris; Nathan Martin; Wyatt Clark; Sanjay Chandriani; Jonathan H LeBowitz; Roberto Giugliani; Alessandra d'Azzo; Gouri Yogalingam; Brett E Crawford
Journal:  Mol Genet Metab Rep       Date:  2019-11-03

7.  Increased levels of acidic free-N-glycans, including multi-antennary and fucosylated structures, in the urine of cancer patients.

Authors:  Ken Hanzawa; Miki Tanaka-Okamoto; Hiroko Murakami; Noriko Suzuki; Mikio Mukai; Hidenori Takahashi; Takeshi Omori; Kenji Ikezawa; Kazuyoshi Ohkawa; Masayuki Ohue; Shunji Natsuka; Yasuhide Miyamoto
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

Review 8.  Exo- and endoglycosidases revisited.

Authors:  Akira Kobata
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.